|
CNNM4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.370400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.972800E-01 |
| Normal-vs-Stage2 |
6.383000E-01 |
| Normal-vs-Stage3 |
1.972970E-01 |
| Normal-vs-Stage4 |
6.965400E-01 |
| Stage1-vs-Stage2 |
5.249200E-01 |
| Stage1-vs-Stage3 |
3.872400E-02 |
| Stage1-vs-Stage4 |
5.950000E-01 |
| Stage2-vs-Stage3 |
3.917800E-01 |
| Stage2-vs-Stage4 |
9.412600E-01 |
| Stage3-vs-Stage4 |
3.663400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.102800E-01 |
| Normal-vs-AfricanAmerican |
8.504200E-01 |
| Normal-vs-Asian |
9.403600E-02 |
| Caucasian-vs-AfricanAmerican |
3.266400E-01 |
| Caucasian-vs-Asian |
1.641650E-02 |
| AfricanAmerican-vs-Asian |
6.570300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.387600E-01 |
| Normal-vs-Female |
9.151800E-01 |
| Male-vs-Female |
1.329230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.298600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.283400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.385600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.919600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.689800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.092400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.192800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.895200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.383400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.213200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.230400E-01 |
| Normal-vs-Grade 2 |
6.297000E-01 |
| Normal-vs-Grade 3 |
7.825600E-01 |
| Normal-vs-Grade 4 |
2.706800E-01 |
| Grade 1-vs-Grade 2 |
1.092200E-01 |
| Grade 1-vs-Grade 3 |
1.959810E-01 |
| Grade 1-vs-Grade 4 |
4.824000E-02 |
| Grade 2-vs-Grade 3 |
7.273800E-01 |
| Grade 2-vs-Grade 4 |
3.232000E-01 |
| Grade 3-vs-Grade 4 |
2.618000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.942800E-01 |
| Normal-vs-ccB subtype |
3.971800E-01 |
| ccA subtype-vs-ccB subtype |
1.619180E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.034600E-01 |
| Normal-vs-N1 |
3.382000E-01 |
| N0-vs-N1 |
1.368430E-01 |
|
|
